APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Nasal Flu Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Nasal Flu Vaccine Market Analysis and Forecast 2026-2032

Report ID 17401580022 January 2026199 pages

Choose your research edition.

Industry ResearchNasal Flu Vaccine Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Nasal Flu Vaccine Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Nasal Flu Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nasal Flu Vaccine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Nasal Flu Vaccine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Nasal Flu Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Nasal Flu Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Nasal Flu Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Nasal Flu Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Nasal Flu Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Nasal Flu Vaccine include AstraZeneca and Beike Bio etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Nasal Flu Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nasal Flu Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Nasal Flu Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nasal Flu Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nasal Flu Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Nasal Flu Vaccine sales, projected growth trends, production technology, application and end-user industry.

Nasal Flu Vaccine Segment by Company

AstraZeneca

Beike Bio

Nasal Flu Vaccine Segment by Type

Trivalent Flu Vaccine

Quadrivalent Flu Vaccine

Nasal Flu Vaccine Segment by Application

Child

Adult

Nasal Flu Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nasal Flu Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nasal Flu Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nasal Flu Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Nasal Flu Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Nasal Flu Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nasal Flu Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nasal Flu Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Trivalent Flu Vaccine Major Manufacturers Table 3. Quadrivalent Flu Vaccine Major Manufacturers Table 4. Global Nasal Flu Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Child Major Manufacturers Table 6. Adult Major Manufacturers Table 7. Nasal Flu Vaccine Industry Trends Table 8. Nasal Flu Vaccine Industry Drivers Table 9. Nasal Flu Vaccine Industry Opportunities and Challenges Table 10. Nasal Flu Vaccine Industry Restraints Table 11. Global Nasal Flu Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Nasal Flu Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Nasal Flu Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Nasal Flu Vaccine Revenue Market Share by Region (2021-2026) Table 15. Global Nasal Flu Vaccine Revenue Market Share by Region (2027-2032) Table 16. Global Nasal Flu Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Nasal Flu Vaccine Sales by Region (2021-2026) & (K Units) Table 18. Global Nasal Flu Vaccine Sales by Region (2027-2032) & (K Units) Table 19. Global Nasal Flu Vaccine Sales Market Share by Region (2021-2026) Table 20. Global Nasal Flu Vaccine Sales Market Share by Region (2027-2032) Table 21. Global Nasal Flu Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Nasal Flu Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Nasal Flu Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Nasal Flu Vaccine Sales Market Share by Manufacturers (2021-2026) Table 25. Global Nasal Flu Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Nasal Flu Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Nasal Flu Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Nasal Flu Vaccine Manufacturers, Product Type & Application Table 29. Global Nasal Flu Vaccine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Nasal Flu Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Nasal Flu Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Nasal Flu Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Nasal Flu Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Nasal Flu Vaccine Revenue Market Share by Type (2021-2026) Table 36. Global Nasal Flu Vaccine Revenue Market Share by Type (2027-2032) Table 37. Global Nasal Flu Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Nasal Flu Vaccine Sales by Type (2021-2026) & (K Units) Table 39. Global Nasal Flu Vaccine Sales by Type (2027-2032) & (K Units) Table 40. Global Nasal Flu Vaccine Sales Market Share by Type (2021-2026) Table 41. Global Nasal Flu Vaccine Sales Market Share by Type (2027-2032) Table 42. Global Nasal Flu Vaccine Price by Type (2021-2026) & (US$/Unit) Table 43. Global Nasal Flu Vaccine Price by Type (2027-2032) & (US$/Unit) Table 44. Global Nasal Flu Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Nasal Flu Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Nasal Flu Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Nasal Flu Vaccine Revenue Market Share by Application (2021-2026) Table 48. Global Nasal Flu Vaccine Revenue Market Share by Application (2027-2032) Table 49. Global Nasal Flu Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Nasal Flu Vaccine Sales by Application (2021-2026) & (K Units) Table 51. Global Nasal Flu Vaccine Sales by Application (2027-2032) & (K Units) Table 52. Global Nasal Flu Vaccine Sales Market Share by Application (2021-2026) Table 53. Global Nasal Flu Vaccine Sales Market Share by Application (2027-2032) Table 54. Global Nasal Flu Vaccine Price by Application (2021-2026) & (US$/Unit) Table 55. Global Nasal Flu Vaccine Price by Application (2027-2032) & (US$/Unit) Table 56. AstraZeneca Company Information Table 57. AstraZeneca Business Overview Table 58. AstraZeneca Nasal Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. AstraZeneca Nasal Flu Vaccine Product Portfolio Table 60. AstraZeneca Recent Development Table 61. Beike Bio Company Information Table 62. Beike Bio Business Overview Table 63. Beike Bio Nasal Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Beike Bio Nasal Flu Vaccine Product Portfolio Table 65. Beike Bio Recent Development Table 66. North America Nasal Flu Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 67. North America Nasal Flu Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 68. North America Nasal Flu Vaccine Sales by Type (2021-2026) & (K Units) Table 69. North America Nasal Flu Vaccine Sales by Type (2027-2032) & (K Units) Table 70. North America Nasal Flu Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 71. North America Nasal Flu Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 72. North America Nasal Flu Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 73. North America Nasal Flu Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 74. North America Nasal Flu Vaccine Sales by Application (2021-2026) & (K Units) Table 75. North America Nasal Flu Vaccine Sales by Application (2027-2032) & (K Units) Table 76. North America Nasal Flu Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 77. North America Nasal Flu Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 78. North America Nasal Flu Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 79. North America Nasal Flu Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 80. North America Nasal Flu Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 81. North America Nasal Flu Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 82. North America Nasal Flu Vaccine Sales by Country (2021-2026) & (K Units) Table 83. North America Nasal Flu Vaccine Sales by Country (2027-2032) & (K Units) Table 84. North America Nasal Flu Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 85. North America Nasal Flu Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 86. United States Nasal Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 87. Canada Nasal Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 88. Europe Nasal Flu Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 89. Europe Nasal Flu Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 90. Europe Nasal Flu Vaccine Sales by Type (2021-2026) & (K Units) Table 91. Europe Nasal Flu Vaccine Sales by Type (2027-2032) & (K Units) Table 92. Europe Nasal Flu Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 93. Europe Nasal Flu Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 94. Europe Nasal Flu Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 95. Europe Nasal Flu Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 96. Europe Nasal Flu Vaccine Sales by Application (2021-2026) & (K Units) Table 97. Europe Nasal Flu Vaccine Sales by Application (2027-2032) & (K Units) Table 98. Europe Nasal Flu Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 99. Europe Nasal Flu Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 100. Europe Nasal Flu Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. Europe Nasal Flu Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 102. Europe Nasal Flu Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 103. Europe Nasal Flu Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 104. Europe Nasal Flu Vaccine Sales by Country (2021-2026) & (K Units) Table 105. Europe Nasal Flu Vaccine Sales by Country (2027-2032) & (K Units) Table 106. Europe Nasal Flu Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 107. Europe Nasal Flu Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 108. Germany Nasal Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 109. France Nasal Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 110. U.K. Nasal Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 111. Italy Nasal Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 112. Netherlands Nasal Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 113. Nordic Countries Nasal Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 114. China Nasal Flu Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 115. China Nasal Flu Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 116. China Nasal Flu Vaccine Sales by Type (2021-2026) & (K Units) Table 117. China Nasal Flu Vaccine Sales by Type (2027-2032) & (K Units) Table 118. China Nasal Flu Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 119. China Nasal Flu Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 120. China Nasal Flu Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 121. China Nasal Flu Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 122. China Nasal Flu Vaccine Sales by Application (2021-2026) & (K Units) Table 123. China Nasal Flu Vaccine Sales by Application (2027-2032) & (K Units) Table 124. China Nasal Flu Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 125. China Nasal Flu Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 126. Asia Nasal Flu Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 127. Asia Nasal Flu Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 128. Asia Nasal Flu Vaccine Sales by Type (2021-2026) & (K Units) Table 129. Asia Nasal Flu Vaccine Sales by Type (2027-2032) & (K Units) Table 130. Asia Nasal Flu Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 131. Asia Nasal Flu Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 132. Asia Nasal Flu Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 133. Asia Nasal Flu Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 134. Asia Nasal Flu Vaccine Sales by Application (2021-2026) & (K Units) Table 135. Asia Nasal Flu Vaccine Sales by Application (2027-2032) & (K Units) Table 136. Asia Nasal Flu Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 137. Asia Nasal Flu Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 138. Asia Nasal Flu Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Asia Nasal Flu Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. Asia Nasal Flu Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. Asia Nasal Flu Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 142. Asia Nasal Flu Vaccine Sales by Country (2021-2026) & (K Units) Table 143. Asia Nasal Flu Vaccine Sales by Country (2027-2032) & (K Units) Table 144. Asia Nasal Flu Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 145. Asia Nasal Flu Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 146. Japan Nasal Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 147. South Korea Nasal Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 148. India Nasal Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 149. Australia Nasal Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 150. China Taiwan Nasal Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 151. Southeast Asia Nasal Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 152. SAMEA Nasal Flu Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 153. SAMEA Nasal Flu Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 154. SAMEA Nasal Flu Vaccine Sales by Type (2021-2026) & (K Units) Table 155. SAMEA Nasal Flu Vaccine Sales by Type (2027-2032) & (K Units) Table 156. SAMEA Nasal Flu Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 157. SAMEA Nasal Flu Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 158. SAMEA Nasal Flu Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 159. SAMEA Nasal Flu Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 160. SAMEA Nasal Flu Vaccine Sales by Application (2021-2026) & (K Units) Table 161. SAMEA Nasal Flu Vaccine Sales by Application (2027-2032) & (K Units) Table 162. SAMEA Nasal Flu Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 163. SAMEA Nasal Flu Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 164. SAMEA Nasal Flu Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. SAMEA Nasal Flu Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. SAMEA Nasal Flu Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. SAMEA Nasal Flu Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 168. SAMEA Nasal Flu Vaccine Sales by Country (2021-2026) & (K Units) Table 169. SAMEA Nasal Flu Vaccine Sales by Country (2027-2032) & (K Units) Table 170. SAMEA Nasal Flu Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 171. SAMEA Nasal Flu Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 172. Brazil Nasal Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 173. Argentina Nasal Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 174. Chile Nasal Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 175. Colombia Nasal Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 176. Peru Nasal Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 177. Saudi Arabia Nasal Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 178. Israel Nasal Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 179. UAE Nasal Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 180. Turkey Nasal Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 181. Iran Nasal Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 182. Egypt Nasal Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Nasal Flu Vaccine Distributors List Table 186. Nasal Flu Vaccine Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Nasal Flu Vaccine Image Figure 2. Global Nasal Flu Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nasal Flu Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Trivalent Flu Vaccine Image Figure 5. Quadrivalent Flu Vaccine Image Figure 6. Global Nasal Flu Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Nasal Flu Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Child Image Figure 9. Adult Image Figure 10. Global Nasal Flu Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Nasal Flu Vaccine Revenue (2021-2032) & (US$ Million) Figure 12. Global Nasal Flu Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Nasal Flu Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Nasal Flu Vaccine Revenue Market Share by Region (2021-2032) Figure 15. Global Nasal Flu Vaccine Sales (2021-2032) & (K Units) Figure 16. Global Nasal Flu Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Nasal Flu Vaccine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Nasal Flu Vaccine Sales YoY (2021-2032) & (K Units) Figure 19. Europe Nasal Flu Vaccine Sales YoY (2021-2032) & (K Units) Figure 20. China Nasal Flu Vaccine Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Nasal Flu Vaccine Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Nasal Flu Vaccine Sales YoY (2021-2032) & (K Units) Figure 23. Global Nasal Flu Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Nasal Flu Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Nasal Flu Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Nasal Flu Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Nasal Flu Vaccine Revenue Market Share by Type (2021-2032) Figure 29. Global Nasal Flu Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Nasal Flu Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Nasal Flu Vaccine Sales Market Share by Type (2021-2032) Figure 32. Global Nasal Flu Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Nasal Flu Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Nasal Flu Vaccine Revenue Market Share by Application (2021-2032) Figure 35. Global Nasal Flu Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Nasal Flu Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Nasal Flu Vaccine Sales Market Share by Application (2021-2032) Figure 38. North America Nasal Flu Vaccine Revenue Share by Type (2021-2032) Figure 39. North America Nasal Flu Vaccine Sales Share by Type (2021-2032) Figure 40. North America Nasal Flu Vaccine Revenue Share by Application (2021-2032) Figure 41. North America Nasal Flu Vaccine Sales Share by Application (2021-2032) Figure 42. North America Nasal Flu Vaccine Revenue Share by Country (2021-2032) Figure 43. North America Nasal Flu Vaccine Sales Share by Country (2021-2032) Figure 44. Europe Nasal Flu Vaccine Revenue Share by Type (2021-2032) Figure 45. Europe Nasal Flu Vaccine Sales Share by Type (2021-2032) Figure 46. Europe Nasal Flu Vaccine Revenue Share by Application (2021-2032) Figure 47. Europe Nasal Flu Vaccine Sales Share by Application (2021-2032) Figure 48. Europe Nasal Flu Vaccine Revenue Share by Country (2021-2032) Figure 49. Europe Nasal Flu Vaccine Sales Share by Country (2021-2032) Figure 50. China Nasal Flu Vaccine Revenue Share by Type (2021-2032) Figure 51. China Nasal Flu Vaccine Sales Share by Type (2021-2032) Figure 52. China Nasal Flu Vaccine Revenue Share by Application (2021-2032) Figure 53. China Nasal Flu Vaccine Sales Share by Application (2021-2032) Figure 54. Asia Nasal Flu Vaccine Revenue Share by Type (2021-2032) Figure 55. Asia Nasal Flu Vaccine Sales Share by Type (2021-2032) Figure 56. Asia Nasal Flu Vaccine Revenue Share by Application (2021-2032) Figure 57. Asia Nasal Flu Vaccine Sales Share by Application (2021-2032) Figure 58. Asia Nasal Flu Vaccine Revenue Share by Country (2021-2032) Figure 59. Asia Nasal Flu Vaccine Sales Share by Country (2021-2032) Figure 60. SAMEA Nasal Flu Vaccine Revenue Share by Type (2021-2032) Figure 61. SAMEA Nasal Flu Vaccine Sales Share by Type (2021-2032) Figure 62. SAMEA Nasal Flu Vaccine Revenue Share by Application (2021-2032) Figure 63. SAMEA Nasal Flu Vaccine Sales Share by Application (2021-2032) Figure 64. SAMEA Nasal Flu Vaccine Revenue Share by Country (2021-2032) Figure 65. SAMEA Nasal Flu Vaccine Sales Share by Country (2021-2032) Figure 66. Nasal Flu Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Nasal Flu Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Trivalent Flu Vaccine
  • Quadrivalent Flu Vaccine
Applications
  • Child
  • Adult
Companies covered
  • AstraZeneca
  • Beike Bio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nasal Flu Vaccine Market by Type
  3. 1.2.1 Global Nasal Flu Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Trivalent Flu Vaccine
  5. 1.2.3 Quadrivalent Flu Vaccine
  6. 1.3 Nasal Flu Vaccine Market by Application
  7. 1.3.1 Global Nasal Flu Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Child
  9. 1.3.3 Adult
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Nasal Flu Vaccine Market Dynamics
  1. 2.1 Nasal Flu Vaccine Industry Trends
  2. 2.2 Nasal Flu Vaccine Industry Drivers
  3. 2.3 Nasal Flu Vaccine Industry Opportunities and Challenges
  4. 2.4 Nasal Flu Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Nasal Flu Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Nasal Flu Vaccine Revenue by Region
  3. 3.2.1 Global Nasal Flu Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nasal Flu Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Nasal Flu Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Nasal Flu Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Nasal Flu Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Nasal Flu Vaccine Sales by Region
  9. 3.4.1 Global Nasal Flu Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Nasal Flu Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Nasal Flu Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Nasal Flu Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Nasal Flu Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Nasal Flu Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Nasal Flu Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Nasal Flu Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nasal Flu Vaccine Sales by Manufacturers
  6. 4.2.1 Global Nasal Flu Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Nasal Flu Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Nasal Flu Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Nasal Flu Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Nasal Flu Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Nasal Flu Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Nasal Flu Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Nasal Flu Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Nasal Flu Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Nasal Flu Vaccine Tier 1, Tier 2, and Tier 3
5 Nasal Flu Vaccine Market by Type
  1. 5.1 Global Nasal Flu Vaccine Revenue by Type
  2. 5.1.1 Global Nasal Flu Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Nasal Flu Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Nasal Flu Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Nasal Flu Vaccine Sales by Type
  6. 5.2.1 Global Nasal Flu Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nasal Flu Vaccine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Nasal Flu Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Nasal Flu Vaccine Price by Type
6 Nasal Flu Vaccine Market by Application
  1. 6.1 Global Nasal Flu Vaccine Revenue by Application
  2. 6.1.1 Global Nasal Flu Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Nasal Flu Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Nasal Flu Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Nasal Flu Vaccine Sales by Application
  6. 6.2.1 Global Nasal Flu Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Nasal Flu Vaccine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Nasal Flu Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Nasal Flu Vaccine Price by Application
7 Company Profiles
  1. 7.1 AstraZeneca
  2. 7.1.1 AstraZeneca Company Information
  3. 7.1.2 AstraZeneca Business Overview
  4. 7.1.3 AstraZeneca Nasal Flu Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 AstraZeneca Nasal Flu Vaccine Product Portfolio
  6. 7.1.5 AstraZeneca Recent Developments
  7. 7.2 Beike Bio
  8. 7.2.1 Beike Bio Company Information
  9. 7.2.2 Beike Bio Business Overview
  10. 7.2.3 Beike Bio Nasal Flu Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Beike Bio Nasal Flu Vaccine Product Portfolio
  12. 7.2.5 Beike Bio Recent Developments
8 North America
  1. 8.1 North America Nasal Flu Vaccine Market Size by Type
  2. 8.1.1 North America Nasal Flu Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Nasal Flu Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Nasal Flu Vaccine Price by Type (2021-2032)
  5. 8.2 North America Nasal Flu Vaccine Market Size by Application
  6. 8.2.1 North America Nasal Flu Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Nasal Flu Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Nasal Flu Vaccine Price by Application (2021-2032)
  9. 8.3 North America Nasal Flu Vaccine Market Size by Country
  10. 8.3.1 North America Nasal Flu Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Nasal Flu Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Nasal Flu Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Nasal Flu Vaccine Market Size by Type
  2. 9.1.1 Europe Nasal Flu Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Nasal Flu Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Nasal Flu Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Nasal Flu Vaccine Market Size by Application
  6. 9.2.1 Europe Nasal Flu Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Nasal Flu Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Nasal Flu Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Nasal Flu Vaccine Market Size by Country
  10. 9.3.1 Europe Nasal Flu Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Nasal Flu Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Nasal Flu Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Nasal Flu Vaccine Market Size by Type
  2. 10.1.1 China Nasal Flu Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Nasal Flu Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Nasal Flu Vaccine Price by Type (2021-2032)
  5. 10.2 China Nasal Flu Vaccine Market Size by Application
  6. 10.2.1 China Nasal Flu Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Nasal Flu Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Nasal Flu Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nasal Flu Vaccine Market Size by Type
  2. 11.1.1 Asia Nasal Flu Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Nasal Flu Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Nasal Flu Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Nasal Flu Vaccine Market Size by Application
  6. 11.2.1 Asia Nasal Flu Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Nasal Flu Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Nasal Flu Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Nasal Flu Vaccine Market Size by Country
  10. 11.3.1 Asia Nasal Flu Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Nasal Flu Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Nasal Flu Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nasal Flu Vaccine Market Size by Type
  2. 12.1.1 SAMEA Nasal Flu Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Nasal Flu Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Nasal Flu Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Nasal Flu Vaccine Market Size by Application
  6. 12.2.1 SAMEA Nasal Flu Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Nasal Flu Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Nasal Flu Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Nasal Flu Vaccine Market Size by Country
  10. 12.3.1 SAMEA Nasal Flu Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Nasal Flu Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Nasal Flu Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Nasal Flu Vaccine Value Chain Analysis
  2. 13.1.1 Nasal Flu Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Nasal Flu Vaccine Production Mode & Process
  6. 13.2 Nasal Flu Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Nasal Flu Vaccine Distributors
  9. 13.2.3 Nasal Flu Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst